53.10
-1.86
(-3.38%)
At close: January 10 at 3:40:06 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
11,750.00
47,173.00
57,245.00
114,721.00
-22,989.00
Investing Cash Flow
-12,098.00
-11,256.00
-167,818.00
50,768.00
100,898.00
Financing Cash Flow
-14,588.00
-29,454.00
90,854.00
-191,857.00
-58,401.00
End Cash Position
33,906.00
107,761.00
101,298.00
121,017.00
147,385.00
Capital Expenditure
-25,384.00
-31,052.00
-206,683.00
-157,112.00
-24,593.00
Free Cash Flow
-13,634.00
16,121.00
-149,438.00
-42,391.00
-47,582.00
3/31/2021 - 12/30/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
INDOCO.NS Indoco Remedies Limited
327.80
-1.90%
WINDLAS.NS Windlas Biotech Limited
988.75
-2.69%
THEMISMED.NS Themis Medicare Limited
260.65
-3.91%
RPGLIFE.NS RPG Life Sciences Limited
2,112.25
-4.40%
NEULANDLAB.NS Neuland Laboratories Limited
14,044.55
-4.02%
SHILPAMED.NS Shilpa Medicare Limited
777.15
-3.91%
IPCALAB.NS Ipca Laboratories Limited
1,632.35
-1.78%
GRANULES.NS Granules India Limited
593.60
-2.05%
MOREPENLAB.NS Morepen Laboratories Limited
68.23
-3.75%
LAURUSLABS.NS Laurus Labs Limited
583.70
-4.79%